Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for U
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g008.png)
Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g002.png)
Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g003.png)
Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML
Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydro
Classification of Orally Administered Drugs on the World Health Organization Model List of Essential Medicines According to the Bio Pharmaceutics Classification System | Bioavailability | Pharmaceutical Drug
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g004.png)
Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML
![Bisphosphonate prodrugs: a new synthetic strategy to tetraacyloxymethyl esters of methylenebisphosphonates - ScienceDirect Bisphosphonate prodrugs: a new synthetic strategy to tetraacyloxymethyl esters of methylenebisphosphonates - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0040403999017992-gr1.gif)